Portola Pharmaceuticals

NCT03310021

Phase 2, Completed, 2017, 108 people, 16 Oct 2017, clinicaltrials.gov

NCT03083704

Phase 1, Completed, 2017, 153 people, 20 Mar 2017, clinicaltrials.gov

NCT01758432

Phase 2, Completed, 2012, 54 people, 1 Jan 2013, clinicaltrials.gov

NCT00742859

Phase 2, Completed, 2008, 508 people, 28 Aug 2008, clinicaltrials.gov